Filing Details

Accession Number:
0000945769-10-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-09 13:00:00
Reporting Period:
2010-04-07
Filing Date:
2010-04-09
Accepted Time:
2010-04-09 14:56:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
887497 Hi Tech Pharmacal Co Inc HITK Pharmaceutical Preparations (2834) 112638720
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1186837 M Martin Goldwyn C/O Tashlik Kreutzer Goldwyn &Amp; Crandell
40 Cuttermill Road
Great Neck NY 11021
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-07 1,750 $8.31 1,750 No 4 M Direct
Common Stock Disposition 2010-04-07 1,750 $22.59 0 No 4 S Direct
Common Stock Acquisiton 2010-04-09 1,000 $13.50 1,000 No 4 M Direct
Common Stock Disposition 2010-04-09 1,000 $22.65 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-04-07 1,750 $0.00 1,750 $8.31
Common Stock Stock Option (Right to Buy) Disposition 2010-04-09 1,000 $0.00 1,000 $13.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,750 2003-12-05 2012-12-05 No 4 M Direct
11,375 2004-11-28 2013-11-28 No 4 M Direct
Footnotes
  1. Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
  2. The options became exercisable in four equal annual installments beginning on the first anniversary of the grant date.
  3. Other than the remaining portions of the options to acquire 6,750 and 11,375 shares, respectively, reflected on this form, the filer is also the holder of additional options to acquire 75,209 shares of the Company's stock (for total options to acquire an aggegate of 93,334 shares held by the filer). The additional options were granted on various dates, with varying exercise prices and exercisable and expiration dates.